Inventor · disambiguated record
Saroja Ramanujan
Also filed as: RAMANUJAN SAROJA
4 granted patents·7 pending applications·18 citations·filing 2017–2025
74Inventor score
Files withGENENTECH INC11
Top patents by PatentIndex Score
11 records- 0192US10752703B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2019·Granted Aug 25, 2020·7 cites·28 claims
- 0285US10738131B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2018·Granted Aug 11, 2020·2 cites·45 claims
- 0383US11939396B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2020·Granted Mar 26, 2024·1 cites·33 claims
- 0483US11466094B2Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodiesGENENTECH INC·Filed 2017·Granted Oct 11, 2022·8 cites·82 claims
- 0582US2024368306A1Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 0681US2024376223A1Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodiesGENENTECH INC·Filed 2024·Application pending·0 cites
- 0779US2024132613A1Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodiesGENENTECH INC·Filed 2023·Application pending·0 cites
- 0876US2023242659A1Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodiesGENENTECH INC·Filed 2023·Application pending·0 cites
- 0970US2025171552A1Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodiesGENENTECH INC·Filed 2025·Application pending·0 cites
- 1067US2024331829A1Quantitative systems pharmacology in cytokine-based cancer immunotherapyGENENTECH INC·Filed 2024·Application pending·0 cites
- 1161US2025239372A1T Cell Quantitative Systems Pharmacology ModelGENENTECH INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Saroja Ramanujan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →